Clinical Trial Detail

NCT ID NCT02333162
Title Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

hematologic cancer

bone marrow cancer

acute myeloid leukemia

Therapies

Mycophenolate mofetil

Tacrolimus

Fludarabine + Melphalan

Age Groups: adult senior

No variant requirements are available.